Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC
Clinical trial NCT04988607 · UNKNOWN
Trial details
- NCT number
- NCT04988607
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2024-11-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.